Royal Capital Wealth Management LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.9% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,418 shares of the healthcare conglomerate’s stock after selling 58 shares during the quarter. UnitedHealth Group accounts for about 2.3% of Royal Capital Wealth Management LLC’s investment portfolio, making the stock its 12th largest position. Royal Capital Wealth Management LLC’s holdings in UnitedHealth Group were worth $3,246,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. White Knight Strategic Wealth Advisors LLC increased its holdings in UnitedHealth Group by 118.5% during the 4th quarter. White Knight Strategic Wealth Advisors LLC now owns 2,856 shares of the healthcare conglomerate’s stock valued at $1,445,000 after purchasing an additional 1,549 shares during the period. Delta Investment Management LLC raised its holdings in UnitedHealth Group by 167.3% in the 4th quarter. Delta Investment Management LLC now owns 6,696 shares of the healthcare conglomerate’s stock worth $3,387,000 after acquiring an additional 4,191 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after acquiring an additional 2,301,010 shares during the period. USS Investment Management Ltd lifted its holdings in UnitedHealth Group by 3.2% in the fourth quarter. USS Investment Management Ltd now owns 484,959 shares of the healthcare conglomerate’s stock valued at $245,605,000 after acquiring an additional 14,897 shares during the period. Finally, Vista Investment Management grew its position in shares of UnitedHealth Group by 3.2% during the 4th quarter. Vista Investment Management now owns 4,199 shares of the healthcare conglomerate’s stock valued at $2,124,000 after acquiring an additional 129 shares during the period. Institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Stock Performance
NYSE:UNH opened at $321.76 on Wednesday. The firm has a market cap of $291.88 billion, a price-to-earnings ratio of 20.76, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a 50-day moving average of $464.33 and a 200-day moving average of $510.17. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.61%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.18%.
Wall Street Analyst Weigh In
A number of equities research analysts recently commented on UNH shares. TD Securities reiterated a “hold” rating and issued a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday. Erste Group Bank downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Mizuho lowered their price target on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research report on Friday, May 16th. Argus downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Finally, Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $677.00 to $351.00 and set an “overweight” rating on the stock in a report on Wednesday, May 14th. Eight research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $451.43.
Check Out Our Latest Analysis on UNH
Insider Activity at UnitedHealth Group
In other news, CFO John F. Rex purchased 17,175 shares of the stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the purchase, the chief financial officer now directly owns 203,796 shares of the company’s stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy Patrick Flynn bought 1,533 shares of the firm’s stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders bought 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is owned by corporate insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- How to Invest in Insurance Companies: A Guide
- Qualcomm’s Re-Entry Into the CPU Market May Not Be Enough
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Applied Digital’s Strategic AI Play Gains Momentum
- Asset Allocation Strategies in Volatile Markets
- Top 5 Stocks Hedge Funds Are Buying Right Now
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.